Olivier Van Till

Company: Mitobridge/Nanna Therapeutics

Job title: Head of Translational Development

Seminars:

Modulating Mitochondrial Function in Patients at Risk for Post-Operative Complications following Cardiac Surgery 10:00 am

Exploring the clinical benefits of modulating mitochondrial function in non-rare disease conditions Modulation of targeted gene expression in patientsRead more

day: Day Two

Roundtable Discussion: Masterminding Mitochondrial Drug Development for Multiple Disease Indications 1:30 pm

Join tables led by mitochondrial drug development experts to discuss the benefits and challenges of different mitochondrial modulation strategies for rare and prevalent disorders. Debating methods of modulation to inform early mitochondrial drug development decisions Balance the distinct safety and clinical considerations of rare and prevalent diseases in relation to modality for regulatory successRead more

day: Day Two